RE: Evening/Morning Guys16 Nov 2020 04:20
Morning LL, nice of you to say so, but only time will tell if it is. Like I said I could have traded this so much better once we broke 10p, having got used to that trading range 6-9p it caught me somewhat rising to 18.5p, and the best trade I actually did was selling the most I ever have by selling 30k at 18.1p, we reached 16.20 pretty sharply and then rose to 16.60 quickly and I rushed back against my better judgement back in. Yes it made my Β£450, but I don"t need to remind us it fell to 10.5p. I am not saying I would have waited till then to buy back but that was a really good position to be in, and the fear of being out did me again!!! So that is why I prefer to say I traded it badly from 10p rather than well even though I made a few bob, and having seen how we reacted to a new trading level feel more confident this time around. I remember at the time scousemark making a big decision about taking profit and he did well on the retrace too, so thats where I want to be.
Was a very volatile week last week, I also tried to sell at 15p, but it took ages to get logged in to H/L and once in every tick down gave the same result NT for just 30k, so I gave up by 13p. I t was the first time I had problems logging in, but so great was the reaction to the Pfizer news it just blocked their system and I couldn"t work out how people were getting to sell at all.
It seemed by Thursday after a bad start when we were sub 11p quite a few PIs came in with probably the refunds they got from the OO, and still IMHO I feel we were very OVERSOLD, still are and will stick to my opinion that we could well see 13p today and a good AGM will see us back to 15p. Dependant on that I won"t be rushing like before to take profits as before I have confidence in what I am hoping for and the question I have with Redmile is why now?? I believe there is a very good reason which we learn about shortly.
Not expecting, but hoping Vulpes continue to add in the market, the amounts are not startling, but it sended a very good message to everybody as to their intentions for the long term. Again I refer to the RNS of 24th September appointing our new NED..........................Susan is an experienced life sciences financier with over 25 years of capital markets and investment banking experience, including Managing Director of Equity Capital Markets at Citigroup Global Markets Limited and most recently until 2018, Managing Director at Torreya Partners LLC, a global investment banking firm serving companies in the Life Sciences industry. Her work at this time included providing advice on M&A, corporate finance, licensing transactions and pharmaceutical asset sales, with clients ranging from large pharmaceutical companies through to private equity firms focused on healthcare. Susan is currently Non-Executive Director and Chairman of the Audit Committee of Evgen Pharma plc, an AIM listed clinical stage drug development company.
To be cont:(